Peretz Partensky

Peretz Partensky is the co-founder and Chief Executive Officer of ImmuneBridge and a Venture Partner at Pioneer Fund, based in San Francisco, California. At ImmuneBridge, he directs the development of off-the-shelf NK cell immunotherapies, recently closing an oversubscribed $12 million seed funding round co-led by Insight Partners and M Ventures. Previously, he served as Vice President of Product and Data at Vim and co-founded Cheetah Technologies, where he operated as Chief Data Scientist and helped the enterprise raise $67 million. Additionally, he co-founded the Y Combinator-backed technology startup Sourcery, acting as Head of Product and a board member to secure $11 million in capital before the company was acquired. Partensky leverages his advanced doctoral education to focus on early-stage venture capital investments and building scalable companies across the biotechnology, predictive analytics, and value-based healthcare sectors.